Issues in the diagnosis and treatment of adult ADHD by primary care physicians

Primary Psychiatry

Volumn 16, Issue 5, 2009, Pages 57-63

  Adler, Lenard ^a   Shaw, David ^a   Sitt, David ^b   Maya, Erica ^a   Ippolito Morrill, Melinda ^c,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Hallowell Center   (United States)

^c Center for Couples and Family Research

^d CLARK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT DISEASE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE;

EID: 75449101208     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Barkley RA. Genetics of childhood disorders: XVII. ADHD, part 1: the executive functions and ADHD. J Am Acad Child Adolesc Psychiatry. 2000;39(8):1064-1068.
2. Spencer T, Biederman J, Wilens T, Faraone SV. Is attention-deficit hyperactivity disorder in adults a valid disorder? Harv Rev Psychiatry. 1994;1(6):326-335.
3. Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology. 2004;18(3):485-503.
4. Biederman J, Monuteaux MC, Mick E, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10 year follow-up study. Psychol Med. 2006;36(2):167-179.
5. Barkley RA. Major life activity and life outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(suppl 12):10-15.
6. Barkley RA. Development course, adult outcome, and clinic-referred ADHD adults. In: Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 2nd ed. New York, NY: Guilford Press; 1998:186-224.
7. Biederman J, Petty C, Fried R, Fontanella J, Doyle AE, Seidman LJ. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 2006;163(10):1730-8.
8. Biederman J, Faraone, SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524-40.
9. Eakin L, Minde K, Hechtman L, et al. The marital and family functioning of adults with ADHD and their spouses. J Atten Disord. 2004;8:1-10.
10. Barkley RA, Murphy KR, Dupaul GI, Bush T. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc. 2002;8(5):655-672.
11. Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003;2(2):104-113.
12. Biederman J, Faraone SV, Keenen K, Knee D, Tsuang MT. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1990;29(4):526-533.
13. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993;50(7):565-576.
14. Weiss G, Hechtman L. Hyperactive Children Grow Up: ADHD in Children, Adolescents, and Adults. 2nd ed. New York, NY: Guilford Press; 1993.
15. Elliot H. Attention deficit hyperactivity disorder in adults: a guide for the primary care physician. South Med J. 2002;95(7):736-742.
16. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the united states: results from the national comorbidity survey replication. Am J Psychiatry. 2006;163(4):716-723.
17. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the united states: results from the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):629-640.
18. Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS. Trends in medication treatment for ADHD. J Atten Disord. 2007;10(4):335-342.
19. Kessler RC, Adler LA, Barkley R, et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry. 2005;57(11):1442-1451.
20. Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol. 2000;15(6):319-328.
21. Wittchen HU, Kessler RC, Beesdo K, Krause P, Hofler M, Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry. 2002;63(suppl 8):24-34.
22. Üstün TB, Sartorius N. Mental Illness in General Health Care: An International Study. Chichester, UK: John Wiley & Sons; 1995.
23. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
24. Sallee F, Smirnov A. Atomoxetine: novel therapy for attention-deficit/ hyperactivity disorder and potential therapeutic implications. Primary Psychiatry. 2003;10(4):41-48.
25. Murphy K, Barkley RA. Attention deficit hyperactivity disorder in adults: comorbidities and adaptive impairments. Compr Psychiatry. 1996;37(6): 393-401.
26. Sachdev P. Attention deficit hyperactivity disorder in adults. Psychol Med. 1999;29(3):507-514.
27. Stein MA, Fischer M, Szumowski E. Evaluation of adults for ADHD. J Am Acad Child Adolesc Psychiatry. 1999;38(8):940-941.
28. Adler LA, Spencer T, Faraone SV, et al. Validity of pilot adult ADHD self-report scale (ASRS) to rate adult ADHD symptoms. Ann Clin Psychiatry. 2006;18(3):145-148.
29. Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-56.
30. Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL. Validity of the world health organization adult ADHD self-report scale (ASRS) screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16(2):52-65.
31. Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist Instructions. Available at: www.med.nyu. edu/psych/assets/adhdscreen18.pdf. Accessed March 31, 2009.
32. Adult Self-Report Scale-V1.1 (ASRS-V1.1) Screener. Available at: www.med.nyu.edu/psych/assets/adhdscreener. pdf. Accessed March 31, 2009.
33. Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007;29(3):450-63.
34. Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang Y. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry. 2007;62(9):970-6.
35. Krishnan S, Montcrief S. Toxicity profile of lisdexamfetamine dimesylate in three independent rat toxicology studies. Basic Clin Pharmacol Toxicol. 2007;101(4):231-40.
36. Krishnan SM, Stark JG. Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers. Curr Med Res Opin. 2008;24(1):33-40.
37. Faraone SV, Upadhyaya HP. The effect of stimulant treatment for ADHD on later substance abuse and the potential for medication misuse, abuse, and diversion. J Clin Psychiatry. 2007;68(11):e28.